UBC

Patient services are undergoing rapid changes based on regulatory requirements and evolving patient and prescriber expectations. Read the full debrief from this year’s Asembia Summit from Senior Director, Patient Access Services Cathy Patten: https://hubs.li/Q02xfrlP0 #PatientsFirst #Asembia24 #Pharma #PatientServices

Are you helping your patients clear nonmedical hurdles to their therapy access and adherence? Go through our social determinants of health scorecard to assess where your patient services program can be optimized to address SDOH challenges: https://hubs.li/Q02wzlVQ0 #PatientsFirst #SDOH #PatientAccess #Pharma

Need to optimize your pharmacovigilance (PV) quality and efficiency? Change is good. Whether you have a vendor change, an acquisition, or a product portfolio expansion, UBC has the comprehensive, customized PV solutions you need and decades of PV system transition experience. Download our Global PV Transition Checklist for critical considerations across your safety system to protect data integrity and regulatory compliance. https://hubs.li/Q02x0t3l0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety

UBC, a leading provider of Risk Evaluation and Mitigation Strategies for biopharma, recently participated in the 7 HL7® FHIR® Connectathon. We successfully implemented REMS administration software; this technology enables the prescriber to be notified of a REMS to ensure safe use when ordering medication for a REMS covered drug. Click here to read the full details. https://hubs.li/Q02vHd9d0 #PatientsFirst #PatientSafety #REMS #RWD #FHIR #Codex #Interoperability #FDA

Are you attending DIA 2024? Discuss making smarter, evidence-based decisions for better patient access and outcomes with UBC's evidence development and safety & risk management teams at booth 2201. Set aside time with us here: https://hubs.li/Q02wXfDL0 #DIA2024 #Pharma #RWE #DrugSafety

UBC's evidence development team will be at ASCO 2024 to discuss how our modernized study designs and execution benefit your patients and accelerate your research. Meet us at booth 37168 or set up time to meet at https://hubs.li/Q02wP0730 #PatientsFirst #ASCO2024 #Oncology #RWE

Meet Laurent Vidal, PhD, UBC Pharmacovigilance expert. Laurent has 14 years of PV experience and holds a PhD in the field of Molecular Medicine. He currently serves as the Associate Director for UBC Global Safety Writing, overseeing, and coordinating aggregate periodic safety reports and conducting safety signal management activities for pharmaceutical products. Click here to learn more. https://hubs.li/Q02vyg6j0

Join UBC tonight at the Citeline Awards as our team finds out if they won the Excellence in Real-World Data/Evidence category. Learn more about this nomination at https://hubs.li/Q02qq9xS0 #PatientsFirst #CitelineAwards #RWD #RWE #Pharma

Are you leveraging AI technology for PV safety writing? Learn how AI/Chat GPT is reshaping aggregate safety reporting and signal management from UBC’s global safety writing experts. Read more about the impact of analytical and generative AI solutions: https://hubs.li/Q02wwQTw0 #PatientsFirst #SafetyandRiskManagement #PatientSafety #Pharmacovigilance #AI

Today is the last day of ISPOR 2024 - stop by booth 101 to meet UBC's team of evidence development experts. We start with strategic evidence generation planning, take a source-agnostic approach to real-world data selection and procurement, and bring decades of experience to operationalizing your study. More at https://hubs.li/Q02w62Xl0 #PatientsFirst #ISPORAnnual #ISPORSummit #ISPOR2024